Searched for
FDA APPROVED HEALTHCARE TECHNOLOGY
Trump administration challenges judge’s order on $100,000 H-1B visa feeThe Trump administration is appealing a federal judge's decision that invalidated a $100,000 fee for H-1B visa applications. A Boston court...- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- FDA pulls 160,000 pounds of frozen pizza snacks from shelves in 21 states over possible metal contaminationMetal contamination frozen snack recall: A popular frozen snack, Farm Rich Pizza Cheese Crunchers, is being recalled. The US Food and Drug ...
- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Carlyle seeks banks for India IPO of healthcare RCM providerCarlyle has sought investment bank pitches for a potential India IPO of its healthcare revenue cycle management platform created through th...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
- Indian diaspora groups welcome court ruling striking down $100,000 H-1B visa feeIndian diaspora groups in the US have lauded a federal court's decision to strike down the $100,000 H-1B visa fee, deeming it a fair move f...
- Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip raceElon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...
- Andhra Cabinet gives nod to 34 proposals; boosts aviation, irrigation, industrial developmentThe Andhra Pradesh Cabinet approved 34 proposals, including a new aviation policy, organ transplantation law, and revised funding for the P...
- 20,000 kg sugar-mixed jaggery, coloured peas seized in Pune food safety department raidsThe FDA in Pune seized 16 tonnes of jaggery and 20 tonnes of sugar intended for adulteration, alongside 68 kg of artificially coloured frie...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Tata Elxsi unveils AnaTel, an AI-powered platform for healthcare software engineering and regulatory complianceTata Elxsi’s AnaTel reflects the growing shift toward AI-native healthcare software engineering, bringing AI-driven automation into regulat...
Load More
